Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Solin, O' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 67 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Zessin, J; Eskola, O; Brust, P; Bergman, J; Steinbach, J; Lehikoinen, P; Solin, O; Johannsen, B
      Synthesis of S-([F-18]fluoromethyl)-(+)-McN5652 as a potential PET radioligand for the serotonin transporter

      NUCLEAR MEDICINE AND BIOLOGY
    2. Bergman, J; Eskola, O; Lehikoinen, P; Solin, O
      Automated synthesis and purification of [F-18]bromofluoromethane at high specific radioactivity

      APPLIED RADIATION AND ISOTOPES
    3. Laakso, A; Bergman, J; Haaparanta, M; Vilkman, H; Solin, O; Syvalahti, E; Hietala, J
      Decreased striatal dopamine transporter binding in vivo in chronic schizophrenia

      SCHIZOPHRENIA RESEARCH
    4. Rinne, JO; Nurmi, E; Ruottinen, HM; Bergman, J; Eskola, O; Solin, O
      [F-18]FDOPA and [F-18]CFT are both sensitive PET markers to detect presynaptic dopaminergic hypofunction in early Parkinson's disease

      SYNAPSE
    5. Ruottinen, HM; Niinivirta, M; Bergman, J; Oikonen, V; Solin, O; Eskola, O; Eronen, E; Sonninen, P; Rinne, UK
      Detection of response to COMT inhibition in FDOPA PET in advanced Parkinson's disease requires prolonged imaging

      SYNAPSE
    6. Nurmi, E; Ruottinen, HM; Bergman, J; Haaparanta, M; Solin, O; Sonninen, P; Rinne, JO
      Rate of progression in Parkinson's disease: A 6-[F-18]fluoro-L-dopa PET study

      MOVEMENT DISORDERS
    7. Bruck, A; Portin, R; Lindell, A; Laihinen, A; Bergman, J; Haaparanta, M; Solin, O; Rinne, JO
      Positron emission tomography shows that impaired frontal lobe functioning in Parkinson's disease is related to dopaminergic hypofunction in the caudate nucleus

      NEUROSCIENCE LETTERS
    8. Gronroos, T; Eskola, I; Lehtio, K; Minn, H; Marjamaki, P; Bergman, J; Haaparanta, M; Forsback, S; Solin, O
      Pharmacokinetics of [F-18]FETNIM: A potential hypoxia marker for PET

      JOURNAL OF NUCLEAR MEDICINE
    9. Lehtio, K; Oikonen, V; Gronroos, T; Eskola, O; Kalliokoski, K; Bergman, J; Solin, O; Grenman, R; Nuutila, P; Minn, H
      Imaging of blood flow and hypoxia in head and neck cancer: Initial evaluation with [O-15]H2O and [F-18]fluoroerythronitroimidazole PET

      JOURNAL OF NUCLEAR MEDICINE
    10. Kaasinen, V; Nurmi, E; Bergman, J; Eskola, O; Solin, O; Sonninen, P; Rinne, JO
      Personality traits and brain dopaminergic function in Parkinson's disease

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    11. Kaasinen, V; Nurmi, E; Bruck, A; Bergman, J; Solin, O; Rinne, JO
      Increased frontal [F-18]fluorodopa uptake in early Parkinson's Disease: sex differences in the prefrontal cortex

      BRAIN
    12. Lapela, M; Eigtved, A; Jyrkkio, S; Grenman, R; Kurki, T; Lindholm, P; Nuutinen, J; Sutinen, E; Solin, O; Bjornskov, I; Bretlau, P; Friberg, L; Holm, S; Jensen, M; Hansen, HS; Minn, H
      Experience in qualitative and quantitative FDG PET in follow-up of patients with suspected recurrence from head and neck cancer

      EUROPEAN JOURNAL OF CANCER
    13. Nurmi, E; Ruottinen, HM; Kaasinen, V; Bergman, J; Haaparanta, M; Solin, O; Rinne, JO
      Progression in Parkinson's disease: A positron emission tomography study with a dopamine transporter ligand [F-18] CFT

      ANNALS OF NEUROLOGY
    14. Laihinen, A; Ruottinen, H; Rinne, JO; Haaparanta, M; Bergman, J; Solin, O; Koskenvuo, M; Marttila, R; Rinne, UK
      Risk for Parkinson's disease: twin studies for the detection of asymptomatic subjects using [F-18]6-fluorodopa PET

      JOURNAL OF NEUROLOGY
    15. Nurmi, E; Bergman, J; Eskola, O; Solin, O; Hinkka, SM; Sonninen, P; Rinne, JO
      Reproducibility and effect of levodopa on dopamine transporter function measurements: A [F-18]CFT PET study

      JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
    16. Ruottinen, HM; Partinen, M; Hublin, C; Bergman, J; Haaparanta, M; Solin, O; Rinne, JO
      An FDOPA PET study in patients with periodic limb movement disorder and restless legs syndrome

      NEUROLOGY
    17. Kahkonen, M; Metsahonkala, L; Minn, H; Utriainen, T; Korhonen, T; Norvasuo-Heila, MK; Harila-Saari, A; Aarimaa, T; Suhonen-Polvi, H; Ruotsalainen, U; Solin, O; Salmi, TT
      Cerebral glucose metabolism in survivors of childhood acute lymphoblastic leukemia

      CANCER
    18. DeJesus, OT; Haaparanta, M; Solin, O; Nickles, RJ
      6-FluoroDOPA metabolism in rat striatum: time course of extracellular metabolites

      BRAIN RESEARCH
    19. Rinne, JO; Portin, R; Ruottinen, H; Nurmi, E; Bergman, J; Haaparanta, M; Solin, O
      Cognitive impairment and the brain dopaminergic system in Parkinson disease - [F-18]fluorodopa positron emission tomographic study

      ARCHIVES OF NEUROLOGY
    20. Salokangas, RKR; Vilkman, H; Ilonen, T; Taiminen, T; Bergman, J; Haaparanta, M; Solin, O; Alanen, A; Syvalahti, E; Hietala, J
      High levels of dopamine activity in the basal ganglia of cigarette smokers

      AMERICAN JOURNAL OF PSYCHIATRY
    21. Laakso, A; Vilkman, H; Alakare, B; Haaparanta, M; Bergman, J; Solin, O; Peurasaari, J; Rakkolainen, V; Syvalahti, E; Hietala, J
      Striatal dopamine transporter binding in neuroleptic-naive patients with schizophrenia studied with positron emission tomography

      AMERICAN JOURNAL OF PSYCHIATRY
    22. Laakso, A; Vilkman, H; Kajander, J; Bergman, J; Haaparanta, M; Solin, O; Hietala, J
      Prediction of detached personality in healthy subjects by low dopamine transporter binding

      AMERICAN JOURNAL OF PSYCHIATRY
    23. Hietala, J; Syvalahti, E; Vilkman, H; Vuorio, K; Rakkolainen, V; Bergman, J; Haaparanta, M; Solin, O; Kuoppamaki, M; Eronen, E; Ruotsalainen, U; Salokangas, RKR
      Depressive symptoms and presynaptic dopamine function in neuroleptic-naiveschizophrenia

      SCHIZOPHRENIA RESEARCH
    24. Rinne, JO; Bergman, J; Ruottinen, H; Haaparanta, M; Eronen, E; Oikonen, V; Sonninen, P; Solin, O
      Striatal uptake of a novel PET ligand, [F-18]beta-CFT, is reduced in earlyParkinson's disease

      SYNAPSE
    25. Suhonen-Polvi, H; Varho, T; Metsahonkala, L; Haataja, L; Ruotsalainen, U; Haaparanta, M; Bergman, J; Solin, O; Aarimaa, T; Holopainen, I; Vainionpaa, L; Manner, T; Jaaskelainen, S; Renlund, M; Sillanpaa, M; Aula, P
      Increased brain glucose utilization in Salla disease (free sialic acid storage disorder)

      JOURNAL OF NUCLEAR MEDICINE
    26. Rinne, JO; Ruottinen, H; Bergman, J; Haaparanta, M; Sonninen, P; Solin, O
      Usefulness of a dopamine transporter PET ligand [F-18]beta-CFT in assessing disability in Parkinson's disease

      JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
    27. Lamusuo, S; Forss, N; Ruottinen, HM; Bergman, J; Makela, JP; Mervaala, E; Solin, O; Rinne, JK; Ruotsalainen, U; Ylinen, A; Vapalahti, M; Hari, R; Rinne, JO
      [F-18]FDG-PET and whole-scalp MEG localization of epileptogenic cortex

      EPILEPSIA
    28. TIIHONEN J; VILKMAN H; RASANEN P; RYYNANEN OP; HAKKO H; BERGMAN J; HAMALAINEN T; LAAKSO A; HAAPARANTASOLIN M; SOLIN O; KUOPPAMAKI M; SYVALAHTI E; HIETALA J
      STRIATAL PRESYNAPTIC DOPAMINE FUNCTION IN TYPE-1 ALCOHOLICS MEASURED WITH POSITRON-EMISSION-TOMOGRAPHY

      Molecular psychiatry
    29. AHO K; LINDBLOM P; OLSSON T; SOLIN O
      PRESSURE-DEPENDENT DECAY OF THE 3P(5)4P CONFIGURATION IN ARGON EXCITED BY ALPHA-PARTICLES AND PROTONS

      Journal of physics. B, Atomic molecular and optical physics (Print)
    30. LAAKSO A; BERGMAN J; HAAPARANTA M; VILKMAN H; SOLIN O; HIETALA J
      [F-18] CFT ([F-18]WIN-35,428), A RADIOLIGAND TO STUDY THE DOPAMINE TRANSPORTER WITH PET - CHARACTERIZATION IN HUMAN-SUBJECTS

      Synapse
    31. LAAKSO A; VILKMAN H; ALAKARE B; HAAPARANTA M; BERGMAN J; SOLIN O; PEURASAARI J; RAKKOLAINEN V; SYVALAHTI EKG; HIETALA J
      ABNORMAL ASYMMETRY OF DOPAMINERGIC NERVE-TERMINALS IN THE CAUDATE-NUCLEUS OF NEUROLEPTIC-NAIVE SCHIZOPHRENIC-PATIENTS

      Nordic journal of psychiatry
    32. LAINE M; YKIJARVINEN H; KIRVELA O; TOLVANEN T; RAITAKARI M; SOLIN O; HAAPARANTA M; KNUUTI J; NUUTILA P
      INSULIN-RESISTANCE OF GLUCOSE-UPTAKE IN SKELETAL-MUSCLE CANNOT BE AMELIORATED BY ENHANCING ENDOTHELIUM-DEPENDENT BLOOD-FLOW IN OBESITY

      The Journal of clinical investigation
    33. BERGMAN J; SOLIN O
      FLUORINE-18-LABELED FLUORINE-GAS FOR SYNTHESIS OF TRACER MOLECULES

      Nuclear medicine and biology
    34. NUUTINEN JM; LESKINEN S; ELOMAA I; MINN H; VARPULA M; SOLIN O; SODERSTROM KO; JOENSUU H; SALMINEN E
      DETECTION OF RESIDUAL TUMORS IN POSTCHEMOTHERAPY TESTICULAR CANCER BYFDG-PET

      European journal of cancer
    35. KINNALA A; NUUTILA P; RUOTSALAINEN U; TERAS M; BERGMAN J; HAAPARANTA M; SOLIN O; KORVENRANTA H; AARIMAA T; WEGELIUS U; KERO P; SUHONENPOLVI H
      CEREBRAL METABOLIC-RATE FOR GLUCOSE AFTER NEONATAL HYPOGLYCEMIA

      Early human development
    36. TARKANYI F; TAKACS S; HESELIUS SJ; SOLIN O; BERGMAN J
      STATIC AND DYNAMIC EFFECTS IN GAS TARGETS USED FOR MEDICAL ISOTOPE PRODUCTION

      Nuclear instruments & methods in physics research. Section A, Accelerators, spectrometers, detectors and associated equipment
    37. LAMUSUO S; RUOTTINEN HM; KNUUTI J; HARKONEN R; RUOTSALAINEN U; BERGMAN J; HAAPARANTA M; SOLIN O; MERVAALA E; NOUSIAINEN U; JAASKELAINEN S; YLINEN A; KALVIAINEN R; RINNE JK; VAPALAHTI M; RINNE JO
      COMPARISON OF [F-18] FDG-PET, [TC-99M]-HMPAO-SPECT, AND [I-123] IOMAZENIL-SPECT IN LOCALIZING THE EPILEPTOGENIC CORTEX

      Journal of Neurology, Neurosurgery and Psychiatry
    38. RUOTTINEN HM; RINNE JO; HAAPARANTA M; SOLIN O; BERGMAN J; OIKONEN VJ; JARVELA I; SANTAVUORI P
      [F-18] FLUORODOPA PET SHOWS STRIATAL DOPAMINERGIC DYSFUNCTION IN JUVENILE NEURONAL CEROID-LIPOFUSCINOSIS

      Journal of Neurology, Neurosurgery and Psychiatry
    39. PAUL R; HAAPARANTA M; BERGMAN J; KAMARAINEN EL; SOLIN O
      IN-VIVO MICRODIALYSIS WITH 2-(F-18)FLUORO-2-DEOXY-D-GLUCOSE FOR STUDYING GLUCOSE-METABOLISM - A NEW METHOD

      Diabetologia
    40. MAKI M; NUUTILA P; LAINE H; VOIPIOPULKKI LM; HAAPARANTA M; SOLIN O; KNUUTI JM
      MYOCARDIAL GLUCOSE-UPTAKE IN PATIENTS WITH NIDDM AND STABLE CORONARY-ARTERY DISEASE

      Diabetes
    41. HAAPARANTA M; BERGMAN J; LAAKSO A; HIETALA J; SOLIN O
      [F-18]CFT ([F-18]WIN-35,428), A RADIOLIGAND TO STUDY THE DOPAMINE TRANSPORTER WITH PET - BIODISTRIBUTION IN RATS

      Synapse
    42. SOLIN O; ENAS JD; BERGMAN J; HAAPARANTA M; VANBROCKLIN HF; BUDINGER TF
      SYNTHESIS OF [F-18] FLUOROATIPAMEZOLE - BIODISTRIBUTION IN RATS

      The Journal of nuclear medicine
    43. RUOTSALAINEN U; SUHONENPOLVI H; ERONEN E; KINNALA A; BERGMAN J; HAAPARANTA M; TERAS M; SOLIN O; WEGELIUS U
      ESTIMATED RADIATION-DOSE TO THE NEWBORN IN FDG-PET STUDIES

      The Journal of nuclear medicine
    44. RAITAKARI M; NUUTILA P; RUOTSALAINEN U; LAINE H; TERAS M; IIDA H; MAKIMATTILA S; UTRIAINEN T; OIKONEN V; SIPILA H; HAAPARANTA M; SOLIN O; WEGELIUS U; KNUUTI J; YKIJARVINEN H
      EVIDENCE FOR DISSOCIATION OF INSULIN STIMULATION OF BLOOD-FLOW AND GLUCOSE-UPTAKE IN HUMAN SKELETAL-MUSCLE - STUDIES USING [O-15]H2O, [F-18] FLUORO-2-DEOXY-D-GLUCOSE, AND POSITRON EMISSION TOMOGRAPHY

      Diabetes
    45. MAKI M; LUOTOLAHTI M; NUUTILA P; IIDA H; VOIPIOPULKKI LM; RUOTSALAINEN U; HAAPARANTA M; SOLIN O; HARTIALA J; HARKONEN R; KNUUTI J
      GLUCOSE-UPTAKE IN THE CHRONICALLY DYSFUNCTIONAL BUT VIABLE MYOCARDIUM

      Circulation
    46. KINNALA A; SUHONENPOLVI H; AARIMAA T; KERO P; KORVENRANTA H; RUOTSALAINEN U; BERGMAN J; HAAPARANTA M; SOLIN O; NUUTILA P; WEGELIUS U
      CEREBRAL METABOLIC-RATE FOR GLUCOSE DURING THE FIRST 6 MONTHS OF LIFE- AN FDG POSITRON EMISSION TOMOGRAPHY STUDY

      Archives of Disease in Childhood
    47. HAAPARANTA M; PAUL R; HUOVINEN R; KUJARI H; BERGMAN J; SOLIN O; KANGAS L
      PHARMACOKINETICS AND METABOLISM OF 2-[F-18]FLUORO-2-DEOXY-D-GLUCOSE (FDG) IN MAMMARY-TUMORS OF ANTIESTROGEN-TREATED RATS

      Nuclear medicine and biology
    48. BERGMAN J; JOHNSTROM P; HAAPARANTA M; SOLIN O; DUELFER T; STONEELANDER S
      RADIOLABELING OF 2-OXOQUAZEPAM WITH ELECTROPHILIC F-18 PREPARED FROM [F-18] FLUORIDE

      Applied radiation and isotopes
    49. DITROI F; TAKACS S; TARKANYI F; FENYVESI A; BERGMAN J; HESELIUS SJ; SOLIN O
      INVESTIGATION OF THE CHARGED-PARTICLE NUCLEAR-REACTIONS ON NATURAL BORON FOR THE PURPOSES OF THE THIN-LAYER ACTIVATION (TLA)

      Nuclear instruments & methods in physics research. Section B, Beam interactions with materials and atoms
    50. SUHONENPOLVI H; RUOTSALAINEN U; KINNALA A; BERGMAN J; HAAPARANTA M; TERAS M; MAKELA P; SOLIN O; WEGELIUS U
      FDG-PET IN EARLY INFANCY - SIMPLIFIED QUANTIFICATION METHODS TO MEASURE CEREBRAL GLUCOSE-UTILIZATION

      The Journal of nuclear medicine
    51. HIETALA J; SYVALAHTI E; VUORIO K; RAKKOLAINEN V; BERGMAN J; HAAPARANTA M; SOLIN O; KUOPPAMAKI M; KIRVELA O; RUOTSALAINEN U; SALOKANGAS RKR
      PRESYNAPTIC DOPAMINE FUNCTION IN STRIATUM OF NEUROLEPTIC-NAIVE SCHIZOPHRENIC-PATIENTS

      Lancet
    52. NUUTILA P; MAKI M; LAINE H; KNUUTI MJ; RUOTSALAINEN U; LUOTOLAHTI M; HAAPARANTA M; SOLIN O; JULA A; KOIVISTO VA; VOIPIOPULKKI LM; YKIJARVINEN H
      INSULIN ACTION ON HEART AND SKELETAL-MUSCLE GLUCOSE-UPTAKE IN ESSENTIAL-HYPERTENSION

      The Journal of clinical investigation
    53. NUUTILA P; KNUUTI MJ; MAKI M; LAINE H; RUOTSALAINEN U; TERAS M; HAAPARANTA M; SOLIN O; YKIJARVINEN H
      GENDER AND INSULIN SENSITIVITY IN THE HEART AND IN SKELETAL-MUSCLES -STUDIES USING POSITRON EMISSION TOMOGRAPHY

      Diabetes
    54. LAPELA M; LESKINEN S; MINN HRI; LINDHOLM P; KLEMI PJ; SODERSTROM KO; BERGMAN J; HAAPARANTA M; RUOTSALAINEN U; SOLIN O; JOENSUU H
      INCREASED GLUCOSE-METABOLISM IN UNTREATED NON-HODGKINS-LYMPHOMA - A STUDY WITH POSITRON EMISSION TOMOGRAPHY AND FLUORINE-18-FLUORODEOXYGLUCOSE

      Blood
    55. BERG LE; LINDBLOM P; OLSSON T; AHO K; HALLSTEN U; SOLIN O
      EXCITATION OF OXYGEN AND NITROGEN IN SOLID KRYPTON AND XENON USING ION-BEAM IRRADIATION

      Journal of physics. B, Atomic molecular and optical physics
    56. AHO K; BERG LE; HALLSTEN U; LINDBLOM P; SOLIN O
      OBSERVATION OF DOMINANT EMISSION OF THE GAYDON-HERMAN GREEN SYSTEM INDENSE NITROGEN EXCITED BY ENERGETIC IONS

      Journal of physics. B, Atomic molecular and optical physics
    57. NUUTILA P; KNUUTI MJ; RAITAKARI M; RUOTSALAINEN U; TERAS M; VOIPIOPULKKI LM; HAAPARANTA M; SOLIN O; WEGELIUS U; YKIJARVINEN H
      EFFECT OF ANTILIPOLYSIS ON HEART AND SKELETAL-MUSCLE GLUCOSE-UPTAKE IN OVERNIGHT FASTED HUMANS

      American journal of physiology: endocrinology and metabolism
    58. AHO K; HALLSTEN U; LINDBLOM P; SOLIN O
      DEEXCITATION PROCESSES OF ATOMS IN DENSE GASES STUDIED BY COMBINING ION-BEAM AND LASER EXCITATION

      Nuclear instruments & methods in physics research. Section B, Beam interactions with materials and atoms
    59. AHO K; BERGMAN J; HALLSTEN U; LINDBLOM P; SOLIN O
      ONLINE MONITORING OF RADIONUCLIDE PRODUCTION TARGETS BY OPTICAL SPECTROSCOPY

      The Journal of nuclear medicine
    60. BERGMAN J; HAAPARANTA M; KAMARAINEN EL; PAUL R; SOLIN O
      MICRODIALYSIS FOR IN-VIVO STUDIES OF GLUCOSE-METABOLISM IN RATS USING2-(F-18)FDG

      The Journal of nuclear medicine
    61. SZUCZ Z; SZELECSENYI F; BERGMAN J; HESELIUS SJ; SOLIN O
      HE-3-INDUCED NUCLEAR-REACTIONS ON BI-209 AT PARTICLE ENERGIES LESS-THAN 28 MEV PRODUCTION OF AT-209

      Radiochimica Acta
    62. NUUTILA P; KNUUTI MJ; HEINONEN OJ; RUOTSALAINEN U; TERAS M; BERGMAN J; SOLIN O; YKIJARVINEN H; VOIPIOPULKKI LM; WEGELIUS U; KOIVISTO VA
      DIFFERENT ALTERATIONS IN THE INSULIN-STIMULATED GLUCOSE-UPTAKE IN THEATHLETES HEART AND SKELETAL-MUSCLE

      The Journal of clinical investigation
    63. YKIJARVINEN H; KNUUTI MJ; MAKI M; LAINE H; RUOTSALAINEN U; TERAS M; SOLIN O; NUUTILA P
      GENDER AND INSULIN SENSITIVITY

      Diabetologia
    64. MAKI M; KNUUTI MJ; YKIJARVINEN H; RUOTSALAINEN U; VOIPIOPULKKI LM; BERGMAN J; SOLIN O; NUUTILA P
      INSULIN-RESISTANCE IS LOCALIZED TO SKELETAL-MUSCLE BUT NOT TO THE HEART IN ESSENTIAL-HYPERTENSION

      Diabetologia
    65. YKIJARVINEN H; MAKI M; KNUUTI J; RUOTSALAINEN U; VOIPIOPULKKI LM; BERGMAN JG; SOLIN O; NUUTILA P
      INSULIN ACTION ON HEART AND SKELETAL-MUSCLE GLUCOSE-UPTAKE IN ESSENTIAL-HYPERTENSION

      Diabetes
    66. BLOMQVIST G; SEITZ RJ; SJOGREN I; HALLDIN C; STONEELANDER S; WIDEN L; SOLIN O; HAAPARANTA M
      REGIONAL CEREBRAL OXIDATIVE AND TOTAL GLUCOSE CONSUMPTION DURING RESTAND ACTIVATION STUDIED WITH POSITRON EMISSION TOMOGRAPHY

      Acta Physiologica Scandinavica
    67. BERGMAN J; KALLMAN KM; SOLIN O; DEJESUS OT; OAKES TR; NICKLES RJ
      A NEW METHOD FOR THE PRODUCTION OF ELECTROPHILIC F-18 STARTING FROM AQUEOUS [F-18] FLUORIDE

      The Journal of nuclear medicine


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 27/02/20 alle ore 16:25:00